Moalifeplus (CEO Han Sangjin) announced on October 22 that its independently developed next-generation universal vaccine platform technology has ...

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

"RNA vaccines and adenovirus-based vaccines (technologies used to develop vaccines against Covid-19) are already in phase two human trials for other infectious diseases like influenza and a different ...

This study identifies DNA packaging changes during adenovirus maturation. Five distinct genomic regions are particularly ...

Avoid financial surprises when getting your puppy’s first shots.

The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.

The HHS intention to award a sole source contract to Rensselaer Polytechnic Institute (RPI) to study an association between vaccinations and autism raised concerns from autism researchers. "Every ...